Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Aziza E, Abdelrahman"'
Autor:
Asmaa Abdullatif, Aziza E. Abdelrahman, Adel Bakry, Shimaa A. Gharieb, Mohamed Sh. Ramadan, Mohamed A. Wasfy, Abdelfatah H. Abdelwanis, Enas M. Fouad
Publikováno v:
Contemporary Oncology, Vol 28, Iss 1, Pp 51-62 (2024)
Externí odkaz:
https://doaj.org/article/d007934370724872a6c049396111daa6
Publikováno v:
Indian Journal of Pathology and Microbiology, Vol 65, Iss 2, Pp 328-335 (2022)
Background: NOTCH1 pathway activation has been recently described to be a key player in gastric carcinogenesis, enhance the survival and proliferation of cancer stem cells (CSCs) and mediate chemoresistance in several malignancies. Aim: This study in
Externí odkaz:
https://doaj.org/article/7b8a235bd8e747d7a76efc34991817c1
Publikováno v:
Türk Patoloji Dergisi, Vol 37, Iss 2, Pp 121-129 (2021)
Objective: As the genetic and molecular profiles of triple negative breast carcinoma (TNBC) are elucidated, multiple therapeutic targets have been produced. TNBC with less than 1% androgen receptor (AR) expression may respond to enzalutamide with gre
Externí odkaz:
https://doaj.org/article/9939cc800117414c9f8862bde431d6f2
Autor:
Anan FATHY, Aziza E. ABDELRAHMAN
Publikováno v:
Türk Patoloji Dergisi, Vol 34, Iss 2, Pp 150-157 (2018)
Objective: Cervical cancer has an increasing incidence in developing countries with a predominance of squamous cell carcinoma. In this work, we aimed to analyze the role of EZH2, Endothelin-1, and CD34 as indicators of the aggressiveness in cervical
Externí odkaz:
https://doaj.org/article/851bfe70f71a48048e494bcac7545278
Autor:
Aziza E, Abdelrahman, Amira, Salem, Ahmed Z, Al Attar, Eman, Elsebai, Walaa, Samy, Mohamed A, Ibrahim, Hanaa M, Ibrahim
Publikováno v:
Applied Immunohistochemistry & Molecular Morphology. 30:713-725
Endometrial cancer (EC) is the most common gynecologic cancer and the current methods for the prediction of its prognosis and treatment response are unfortunately suboptimal. In this study, we evaluated the prognostic value of p53, Pirh2, and L1CAM i
Publikováno v:
Türk Patoloji Dergisi, Vol 33, Iss 3, Pp 198-210 (2017)
Objective: There is an urgent need to identify molecular biomarkers rather than clinical markers to distinguish aggressive prostate cancer from the indolent majority for proper treatment and accurate prediction of prognosis. We aimed to investigate t
Externí odkaz:
https://doaj.org/article/8a1cef2706ec4ae893a79944f12869d0
Publikováno v:
Türk Patoloji Dergisi, Vol 33, Iss 3, Pp 211-222 (2017)
Objective: Programmed cell death ligand-1 interacts with the immune receptors on the surface of CD8+ tumor infiltrating lymphocytes and PD-1, thereby blocking its anti-tumor activity. Therapeutics suppression of this interaction will show a promise i
Externí odkaz:
https://doaj.org/article/90be0a8b61394c2698fe07501c782c62
Autor:
Aziza E. Abdelrahman, Asmaa Abdullatif
Publikováno v:
Zagazig University Medical Journal.
Autor:
Hanaa Ibrahim, Aziza E. Abdelrahman, Amira Elwan, Eman Elsebai, Ahmed Eliwa, Samah S. Elbasateeny
Publikováno v:
Zagazig University Medical Journal.
Autor:
Marwa AbdEl-Moniem Amer, Amira Mohamed Abdelhamid, Aziza E. Abdelrahman, Mostafa M. Toam, Shireen Sami Mahmoud, Nelly Mohamed Said, Walaa Samy
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology. 393:2411-2425
Cisplatin and oxaliplatin are widely used anticancer drugs. Their use is restricted by their dose-limiting side effects: nephrotoxicity and neurotoxicity, respectively. Cerium oxide nanoparticles (CONPs) are promising antioxidant and anti-inflammator